While biological segments, like biofungicides and biopesticides, have flooded the market in recent years, the bioherbicide segment continues to lag behind in development. Steve Pearce, Co-founder and Chairman of Accumont, and Pam Marrone, Ph.D., Co-founder and Executive Chair of the Invasive Species Corp., discuss bioherbicide market evolution, challenges for broader adoption, and the future of breakout products.
2026 Biologicals Deep Dive: Biggest Product Gap
Previous
Previous
H.A.R.V.E.S.T.™ AgTech Launches with First Cohort of Seven Startups Pioneering the Future of Agricultural Biologicals
Next
Next